Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$8.04 - $9.0 $342,166 - $383,022
42,558 Added 70.24%
103,144 $864,000
Q1 2023

May 16, 2023

SELL
$7.57 - $8.37 $857,786 - $948,438
-113,314 Reduced 65.16%
60,586 $493,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $440,444 - $595,634
73,900 Added 73.9%
173,900 $1.39 Million
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $563,000 - $750,000
100,000 New
100,000 $609,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Susquehanna International Group Ltd. Portfolio

Follow Susquehanna International Group Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group Ltd. with notifications on news.